Lexicon Pharmaceuticals to Attend the Jefferies 2025 London Healthcare Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 11 2025
0mins
Source: Globenewswire
Company Announcement: Lexicon Pharmaceuticals will participate in a fireside chat at the Jefferies 2025 London Healthcare Conference on November 18, 2025, at 5:00 p.m. GMT.
Access to Event: The live event and replays can be accessed through the Events page on Lexicon's website.
About Lexicon Pharmaceuticals: Lexicon is a biopharmaceutical company focused on developing innovative medicines through its Genome5000™ program, which has identified over 100 therapeutic protein targets.
Research and Development: The company has advanced multiple medicines to market and has a pipeline targeting various conditions, including heart failure, neuropathic pain, and diabetes.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
